<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33616">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02110719</url>
  </required_header>
  <id_info>
    <org_study_id>REAG00414HU</org_study_id>
    <nct_id>NCT02110719</nct_id>
  </id_info>
  <brief_title>A Multimodal Pain Pathway in Urogynecologic Surgery</brief_title>
  <acronym>Pain</acronym>
  <official_title>A Multi-modal Pain Pathway in Urogynecologic Surgery: A Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hartford Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hartford Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In recent years, there has been an emphasis on the creation of &quot;enhanced-recovery&quot;,
      &quot;fast-track&quot; or &quot;multi-modal&quot; pathways to improve perioperative care (1-4). The goal of
      these programs is to reduce the length of hospital stay, decrease narcotic usage while
      improving pain control, accelerate post-operative recovery, and expedite return to baseline
      functional status. Pathways often are developed by a team of surgeons, nurses, pain
      specialists, anesthesiologists and other support staff. These pathways include preoperative,
      intraoperative and postoperative components. Preoperative components involve optimization of
      chronic medical conditions prior to surgery, counseling on surgical expectations and
      postoperative recovery, limiting preoperative fasting, and cessation of harmful habits
      including smoking and alcohol use. Intraoperative components include temperature
      maintenance, fluid balance, avoidance of nasogastric tubes, avoidance of unnecessary
      peritoneal drains and mechanical bowel preparation, and appropriate analgesia. Postoperative
      components often involve multi-modal analgesia, early return to activity and early return to
      a regular diet.   The goal of this study is to evaluate the efficacy of a multi-modal pain
      regimen in the field of Urogynecology.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>postop day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain will evaluated using a validated pain scale on postoperative day number 1.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>one week postop</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain will be evaluated using a validated pain scale at one week postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Constipation</measure>
    <time_frame>1 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>Constipation will be evaluated at the 1 week time point.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">156</enrollment>
  <condition>Pain</condition>
  <condition>Constipation</condition>
  <condition>Nausea</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be given the following:
no preoperative medications
intraoperative medications per anesthesia
postoperatively, patients will receive ibuprofen, tylenol and narcotics as needed</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multimodal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the multimodal arm will receive the following:
preoperative celebrex and gabapentin
intraoperative IV acetaminophen, dexamethasone, zofran
postoperative scheduled IV acetaminophen, PO celebrex and gabapentin, and as needed PO narcotics
patient will be discharged on scheduled ibuprofen and acetaminophen for 3 days followed by &quot;as needed&quot; use as well as &quot;as needed&quot; narcotics</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Multimodal</intervention_name>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_label>Multimodal</arm_group_label>
    <other_name>Celebrex</other_name>
    <other_name>Gabapentin</other_name>
    <other_name>IV acetaminophen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  women &gt;/= 18 years old

          -  undergoing pelvic organ prolapse or incontinence surgery with the Urogynecology
             department

        Exclusion Criteria:

          -  males

          -  &lt;18 years old

          -  women unwilling or unable to consent

          -  same-day-discharge surgery

          -  history of chronic pain for which they use medications

          -  current or active history of narcotic abuse

          -  sleep apnea

          -  liver or kidney dysfunction

          -  sulfa allergy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Krista Reagan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hartford Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Krista M Reagan, MD</last_name>
    <phone>860-545-4338</phone>
    <phone_ext>4005</phone_ext>
    <email>krista.reagan@hhchealth.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hartford Hosptial</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krista Reagan, MD</last_name>
      <phone>860-545-4338</phone>
      <phone_ext>4005</phone_ext>
      <email>krista.reagan@hhchealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Adam Steinberg, DO</last_name>
      <phone>860-545-4338</phone>
    </contact_backup>
    <investigator>
      <last_name>Krista Reagan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Steinberg, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David O'Sullivan, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 8, 2014</lastchanged_date>
  <firstreceived_date>April 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>constipation</keyword>
  <keyword>nausea</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Nausea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
    <mesh_term>Gabapentin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
